Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-007551

President sold 30,000 shares at an average $57.26 ($1,717,843)

  • President acquired 30,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

RUBINSTEIN JULIE · President

Table I: Non-derivative

7 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-01 Exercise or conversion : show line 1 in the form +15,000 $6.32 $94,800 15,000 D
2021-02-01 Sale : show line 2 in the form −10,945 $55.36 $605,915 4,055 D
2021-02-01 Sale : show line 3 in the form −4,055 $56.01 $227,121 0 D
2021-02-02 Exercise or conversion : show line 4 in the form +15,000 $6.32 $94,800 15,000 D
2021-02-02 Sale : show line 5 in the form −7,710 $58.58 $451,652 7,290 D
2021-02-02 Sale : show line 6 in the form −5,280 $59.20 $312,576 2,010 D
2021-02-02 Sale : show line 7 in the form −2,010 $59.99 $120,580 0 D
Open-market sales · 30,000 sh · avg $57.26 · $1,717,843

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-02-01 Exercise or conversion : show line 8 in the form Stock Option (Right to Buy) −15,000 80,000 D
2021-02-02 Exercise or conversion : show line 9 in the form Stock Option (Right to Buy) −15,000 65,000 D
Loading xslF345X03/doc4.xml…